Bioverativ Inc. is an American multinational biotechnology company headquartered in Rockville, Maryland. The company was founded in 1998 and is a leading developer of biological therapies for the treatment of serious diseases. Bioverativ has a portfolio of products that include anti-cancer drugs, immunotherapies, and gene therapy products. The company has operations in more than 60 countries.  Bioverativ is the developer of biological therapies for the treatment of serious diseases. The company has a portfolio of products that include anti-cancer drugs, immunotherapies, and gene therapy products. Bioverativ has operations in more than 60 countries.
